The place of Cetraria islandica in the treatment of acute respiratory viral infection


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Acute respiratory viral infections (ARVI) are a large etiologically heterogeneous group of infectious diseases occurring with damage to the upper and lower respiratory tract. The development of the inflammatory process in the mucous membrane of the respiratory tract in ARVI significantly increases the sensitivity of the cough receptors, which decreases when the inflammation is stopped. The new concept of the pathogenesis of cough as a manifestation of hypersensitivity assumes that the basis of treatment is drugs that demonstrate both anti-inflammatory and antitussive properties. As a rule, phytopreparations intended for the treatment of cough have such a combination of effects. These drugs are more effective, they are characterized by prolonged and multidirectional pharmacological action.

全文:

受限制的访问

作者简介

Irina Klyachkina

Russian Medical Academy of Continuous Professional Education

Email: formozailk2012@yandex.ru
Cand. Sci. (Med.), Associate Professor at the Department of Pulmonology Moscow, Russia

参考

  1. Boujaoude Z.C., Pratter M.R. Clinical approach to acute cough. Lung. 2010;188(Suppl. 1):41-6. doi: 10.1007/s00408-009-9170-6.
  2. Mourtzoukou E.G., Falagas M.E. Exposure to cold and respiratory tract infections. Int J Tuberc bung Dis. 2007;H(9):938-43.
  3. Eccles R., Wilkinson J.E. Exposure to cold and acute upper respiratory tract infection* Rhinol. 2015;53:99-106. doi: 10.4193/Rhino14.239.
  4. Mäkinen E.M., Juvonen R., Jokelainen J., et al. Cold temperature and low humidity are associated with increase occurrence of respiratory tract infections Respir Med. 2009;103(3):456-62. Doi: 10.1016/j. rmed.2008.09.011.
  5. Зайцев А.А., Клочков О.И., Миронов М.Б., Синопальников А.И. Острые респираторные вирусные инфекции: этиология, диагностика, лечение и профилактика. М., 2008. 37 с
  6. Крюков А.И., Туровский А.Б., Колбанова И.Гидр. Основные принципы лечения острой респиратор -ной вирусной инфекции. РМЖ. 2019;8(I):46-50
  7. Jackson G., Dowling H., Spiesman I., Boand A. Transmission of the Common Cold to Volunteers under Controlled Conditions. Common Cold as a Clinical Entity. JAMA. Internal Med. 1958;101:267-78. Doi: 10.W01/archinte.1958.00260140099015.
  8. Gwaltney J.M., Hendley J.O., Simon G., Jordan W.S. Rhinovirus Infections in an Industrial Population. II. Characteristics of Illness and Antibody Response. JAMA. 1967;202:494-500.
  9. Синопальников А.И., Клячкина И.Л. Кашель. М., 2013. 168 с.
  10. Шварц Л.С. Кашель. Большая Медицинская Энциклопедия. Второе издание. Т. 12. М., 1959. С. 514-39
  11. Mazzone S.B., Farrell M.J. Heterogeneity of cough neurobiology: clinical implications. Pulm Pharmacol Ther. 2019;55:62-6. Doi: 10.1016/j. pupt.2019.02.002.
  12. O'Connell F., Thomas V.E., Studham J.M., et al. Capsaicin cough sensitivity increases during upper respiratory infection. Respir Med. 1996;90:279-86. doi: 10.1016/s0954-6111(96)90099-2.
  13. Dicpinigaitis P.V., Bhat R., Rhoton W.A., et al. Effect of viral upper respiratory tract infection on the urge-to-cough sensation. Respir Med. 2011;105(4):615-doi: 10.1016/j.rmed.2010.12.002.
  14. Chung K.F., Canning B., McGarvey L. Eight International London Cough Symposium 2014: Cough hypersensitivity syndrome as the basis for chronic cough. Pulm Pharmacol Ther. 2015;35:76-80. doi: 10.1016/j.pupt.2015.08.009.
  15. Morice A.H., Kantar A., Dicpinigaitis P.V., et. al. Treating acute cough: wet versus dry - have we got the paradigm wrong? ERJ. Open Res. 2015;1(2):00055-2015. doi: 10.1183/23120541.00055-2015.
  16. Eccles R., Webber O. (eds). Over the Counter Medicines for Colds. Common Cold, Birkhauser Verlag, Basel, 2009. С. 249-73.
  17. Клячкина И.Л., Синопальников А.И. Мукоактивные препараты. В книге: Рациональная фармакотерапия заболеваний органов дыхания: руководство для врачей. 2-е изд., испр. и доп. Глава 8. С. 103-18. М., 2013. 872 с
  18. Коберник А.А., Кравченко И.А., Червоненко Е.Ф. и др. Идентификация биологически активных веществ в слоевище Cetraria Islandica. Актуальные проблемы транспортной медицины. 2015;2(40):144-48
  19. Firmenschrift: 100 Jahre Engelhard Arzneimittel. FrankfurT., 1972.
  20. Kempe C., Pruning H., Stasche N., Hormann K. Icelandic moss lozenges in the prevention of treatment of oral mucosa irritation and dried out throat mucosa. Laryngorhinootol. 1997;76(3):186-doi: 10.1055/s-2007-997409.
  21. Hecker M., Votp A. Tolerability of Icelandic moss lozenges in upper respiratory tract diseases - multicentric drug monitoring study with 3.143 children. Forsch Komplementarmed Klass Naturheilkd. 2004;1(2):76-82. doi: 10.1159/000078228.
  22. Лузина О.А., Салахутдинов Н.Ф. Биологическая активность усниновой кислоты и ее производных. Часть 1. Активность в отношении одноклеточных организмов. Биоорганическая химия. 2016;2(42):129-49
  23. Wood S., Huffman J., Weber N., et al. Antiviral activity of naturally occurring anthraquinones and anthraquinone derivatives. Planta Med. 1990;56:651-52.
  24. Neamati N., Hong H., Mazumder A., et al. Depsides and depsidones as inhibitors of HIV-1 integrase: discovery of novel inhibitors through 3D database searching. J Med Chem. 1997;40:942-51. doi: 10.1021/jm960759e.
  25. Schmeda-Hirschmann G., Tapia A,.Lima B., et al. A new antifungal and antiprotozoal depside from the Andean lichen. Protousnea Poeppigii. Phytother Res. 2008;22:349-55. doi: 10.1002/ptr.2321.
  26. Schmidgall J., Schnetz E., Hensel A. Evidence for Bioadgesive Effects of Polysaccharides and Polysaccharide-Containing Herbs. Planta Med. 2000;66:48-53. doi: 10.1055/s-2000-11118.
  27. Franz G. Polysaccharides in Pharmacy: Current Applications and Future Concepts. Planta Med. 1989;55:493-97. doi: 10.1055/s-2006-962078.
  28. Morton J.F. Mucilaginous Plants and Their Uses in Medicine. Ethnopharmacol. 1990;29:245-66. doi: 10.1016/0378-8741(90)90036-s.
  29. Noslova G., Strapkova K., Kardosova A., Capek P., et al. Antitussive Action of Extracts and Polysaccharides of Marsh Mallow (Althea Officinalis L., Var. Robusta). Pharmazie. 1992;47:223-26.
  30. Криштанова Н.А., Сафонова М.Ю., Болотова В.Ц., Павлова Е.Д. Перспективы использования растительных полисахаридов в качестве лечебных и лечебно-профилактических средств. Вестник ВГУ. 2005;1:212-21
  31. Shrestha G., Clair L.L., O'Neill K.L. The Immunostimulating Role of Lichen Polysaccharides: A Rev. Phytother. Res. 2015;29(3):317-22. doi: 10.1002/ptr.5251.
  32. Оспищева Л.А. Оболенцева Г.В., Сербин А.Г О противовоспалительных и гемостатических свойствах некоторых полифенолов и растительных полисахаридов. Результаты и перспективы научных исследований в области создания лекарств из растительного сырья. М., 1985. С. 110-4.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2021
##common.cookie##